Advertisements



We are Sorry, This Page doesn't Exist


Prevail temporarily suspended screening, enrollment for PROPEL Phase 1/2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 26th, 2020

Prevail Therapeutics Reports Full Year 2019 Financial Results and Business Highlights

Dosing Initiated in PROPEL Phase 1/2 Trial of PR001 for Treatment of Parkinson's Disease with GBA1 Mutations Preparations Underway to Initiate PROVIDE Phase 1/2 Trial of PR001 .....»»

Category: earningsSource: benzingaMar 26th, 2020

Cara Therapeutics expects interim analysis from Phase 2 trial in AD in Q2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 25th, 2020

Applied Therapeutics expects topline data from ARISE-HF trial in 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 13th, 2020

Prevail "on track" to report interim data from PR001 PROPEL trial in 2H20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 3rd, 2020

ProQR Therapeutics expects initial data from Phase 2/2 Aurora trial in 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2020

vTv Therapeutics to complete Phase 2 of Alzheimer’s study by 2021

vTv Therapeutics (NSDQ:VTVT), the High Point biopharmaceutical company, expects to complete Phase 2 of its Alzheimer’s disease study by 2021.  The clinical trial for azeliragon, a drug created by the company to slow or halt the progression of t.....»»

Category: topSource: bizjournalsDec 19th, 2019

Entasis Therapeutics expects data from Phase 3 trial of zoliflodacin in 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Opened Enrollment of PROPEL Phase 1/2 Trial of PR001 to Treat Parkinson's Disease Patients with G.....»»

Category: earningsSource: benzingaNov 12th, 2019

Immutep expects to report final safety data for TACTI-mel trial in 1H20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 28th, 2019

Auris Medical expects interim analysis of TRAVERS Phase 2 trial in Q4 or 1Q20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019

Oragenics reports interim safety analysis results from Phase 2 AG013 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2018

The best car rental companies in 2021

Here are the best car rentals of 2021 based on prices, locations, cancellation policies, reviews, and COVID-19 safety.....»»

Category: personnelSource: nytJan 21st, 2021

Marriott Vacations Worldwide Announces Preliminary Fourth Quarter 2020 Results

ORLANDO, Fla., Jan. 20, 2021 /PRNewswire/ -- Marriott Vacations Worldwide Corporation (NYSE:VAC) announced today that it expects to report the following preliminary fourth quarter 2020 results.  .....»»

Category: earningsSource: benzingaJan 20th, 2021

Urban Tea Subsidiary Achieves Earn-out Commitment and Urban Tea Expects 400% Increase in Total Revenues For Fiscal Year Ending 6/30/2021

CHANGSH.....»»

Category: earningsSource: benzingaJan 20th, 2021

5 Stocks To Watch For January 20, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Procter & Gamble Co (NYSE: PG) to report quarterly earnings at $1.51 per share on revenue of $19.27 billion before the opening bell. Procter & Gamble shares gained 0.3% to $.....»»

Category: earningsSource: benzingaJan 20th, 2021

Alpha short Mesoblast, expects chronic lower back pain Phase 3 trial to fail

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

Halliburton expects free cash flow to "more than double" in 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

Marimed CEO expects cannabis industry to continue to thrive in 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

The IEA expects global oil demand to recover more slowly in early 2021, before staging a stronger comeback in the second half this year

Global consumption is now expected to.....»»

Category: personnelSource: nytJan 19th, 2021